HomeNewsBusinessPersonal FinanceCOVID-19 EPF advance 2.0: Should you withdraw your PF?

COVID-19 EPF advance 2.0: Should you withdraw your PF?

Withdrawal option allowed last year extended; will also cover those affected by Mucormycosis

Mumbai / June 07, 2021 / 08:22 IST
Story continues below Advertisement

After COVID-19 first wave hit the Indian shores last year, the central government and regulators had scrambled to roll out relief measures for the economy and individuals.

Allowing employees to dip into their employees’ provident fund (EPF)  corpus to tide over the COVID-19-induced financial crunch was amongst the key measures and a number of employees did utilise this option. As on May 31, Employees Provident Fund Organisation (EPFO) had settled over 76.31 lakh COVID-19 advance claims, with disbursals amounting to Rs 18,698.15 crore. Now, this relaxation has been extended further due to the second wave. Such claims will be prioritised and settled by the EPFO within three days.

Story continues below Advertisement

In addition, the labour ministry has also brought the dreaded Mucormycosis or Black Fungus into the ambit. Terms, conditions and the procedure for the making the withdrawal remain unchanged. The withdrawal will not attract any tax.

However, financial planners caution against making use of the facility simply because it’s available, without exploring alternatives. “A withdrawal from your EPF corpus to meet short-term needs would mean losing out on future compounding benefits. Look to take loans against fixed deposits and gold that is lying in your house unutilised. Your losses will be lower in such cases. EPF is a long-term retirement benefit that you need for your future security,” explains Mrin Agarwal, Founder-Director, Finsafe.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show